Safety Assessment RP1388 Zinc Chelate of Hydroxy Analogue of Methionine

The Food Standards Agency (FSA) and Food Standards Scotland (FSS) have undertaken an assessment of application RP1388 for the renewal of zinc chelate of hydroxy analogue of methionine (≥17% zinc and ≥79% DL-methionine hydroxy analogue, (HMTBa)1) for use in all species, from Novus Europe S.A./N.V., Woluwe Atrium - 5th Floor, Rue Nerveldstraat 101-103, BE-1200, Brussels, Belgium (category: nutritional additives; functional group: compounds of trace elements, as a source of zinc and the essential amino acid methionine in the feed). A feed additive application has been received by Great Britain (GB) where EFSA, prior to the end of the transition period, evaluated an application for the product. FSA/FSS have reviewed the EFSA opinion (EFSA Journal 2020;18(12):6337,11 pp.) and confirm that it is adequate and relevant for GB risk analysis and used this to form the basis of GB opinion. The FSA/FSS risk assessors concluded that the EFSA opinion is adequate and relevant for GB risk analysis. Therefore, the use of zinc chelate of hydroxy analogue of methionine, as described in this application, is safe and is not liable to have an adverse effect on the target species, worker safety, environmental safety and human health at the intended concentrations of use. There are no specific conditions or restrictions in relation to labelling, post-market monitoring requirements and use of this additive as described in this application. Maximum Residue Limits (MRLs) are not required for this additive. For user safety, breathing protection, safety glasses and gloves should be worn during handling.